&
funded under the Excellence Initiative program
The Interdisciplinary Thematic Institutes (ITI) were created on January 1, 2021 by the University of Strasbourg and its partners CNRS and INSERM. Fifteen thematic have been selected under the scrutiny of an international scientific committee. The objective of the ITI InnoVec is to develop education and research on drug delivery systems.
The challenge of the ITI InnoVec is the development of new strategies for the vectorization of tomorrow's drugs.
The creation of the InnoVec ITI starts from the scientific observation that a specific active substance can only gain therapeutic application if it reaches its molecular targets at the right time and dose without promoting side effects. Biomolecules such as nucleic acids have therapeutic potentials that are unraveled only with the use of effective carriers. Strategies strategies for the "vectorization" of active molecules to promote their delivery to the site of action, at the right dose, at the right time and during the right duration, offer enormous potential to improve the therapeutic effectiveness of the active molecules available in the current pharmacopoeia and those that will be developed in the future.
InnoVec brings together researchers of complementary expertise in the fields of vectorization, cell signaling, chemistry and engineering sciences. This interdisciplinary approach makes possible to promote innovative research for the vectorization of biomolecules that integrates the development of new molecules and vectors, but also innovative and relevant molecular, cellular and pluricellular models to get closer to the complexity of a living organism.
To bring together research from different discipline to work together and to respond to major scientific challenges in the field of vectorization
To participate in the development of biomolecules vectorization technologies for human health applications